They could perhaps see sustained runs beyond this year.

Artificial intelligence (AI) isn't the only industry with explosive growth potential.

Uncover the systematic approach to biotech firm valuation using DCF. Equip yourself with the knowledge to gauge company ...

Biotech headwinds are driving double-digit revenue growth and profitability for these two mid-caps.

Healthcare stocks rebounded in 2025. These three healthcare growth stocks offer exposure to innovation beyond traditional ...

Biotech stocks are in focus as analysts track upcoming clinical data and regulatory decisions in autoimmune and rare disease ...

The words “sure-fire” and biotechnology stocks rarely go together. This is a sector of the stock market that carries ...

Investing.com -- The biotechnology sector continues to offer compelling investment opportunities in 2026, with several companies poised for significant growth according to Bank of America analysts.

The volatile biotech industry has put up a strong performance in 2025 despite the uncertain macroeconomic environment. While the tariff saga hit the pharma/biotech industry earlier in the year, the ...

Biotech firms should profit from the ‘patent cliff’, which will force big pharmaceutical companies to innovate or make ...

Other useful metrics include insider buying and levels of short activity, which offer stronger predictive signals than ...